文献速递流行病学与生物统计基础与转化研究

未治疗潜伏结核感染者发病绝对风险的系统综述与荟萃分析

Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2020-03-10

该系统综述与荟萃分析纳入122项研究,评估未治疗且结核菌素皮试(TST)或干扰素γ释放试验(IGRA)阳性人群的结核病年发病率。结果显示,不同高危人群发病率差异显著,接触者、HIV感染者、移民、矽肺、透析、移植受者及囚犯中发病率较高,阳性者较阴性者发病率比显著升高。

要点

  • TST≥10mm一般人群结核年发病率0.3/1000人年。
  • 接触者中IGRA阳性者年发病率17.0/1000人年。
  • HIV感染者中TST≥5mm阳性者年发病率27.1/1000人年。

核心结论

  • 多个高危人群在TST或IGRA阳性后结核病发病率较高。
  • 该综述信息有助于指导潜伏结核感染的检测与治疗临床决策。

研究设计与样本

  • 系统综述与荟萃分析,检索Embase、Medline和Cochrane对照试验注册库(1990年1月1日至2019年5月17日)。
  • 纳入至少10例未治疗且结核抗原检测阳性、随访至少12个月的回顾性或前瞻性队列及随机试验。
  • 共纳入122项研究,采用随机效应广义线性混合模型合并数据。

主要发现

  • 所有类型结核接触者中,IGRA阳性者年发病率17.0/1000人年(95%CI 12.9-22.4),TST≥5mm阳性者8.4/1000人年(95%CI 5.6-12.6)。
  • HIV感染者中,IGRA阳性者年发病率16.9/1000人年(95%CI 10.5-27.3),TST≥5mm阳性者27.1/1000人年(95%CI 15.0-49.0)。
  • 移民、矽肺、需透析者、移植受者及囚犯发病率也较高。
  • 几乎所有风险组中,检测阳性者较阴性者的发病率比显著大于1.0。

关键数值与推荐

  • 一般人群TST≥10mm者年发病率0.3/1000人年(95%CI 0.1-1.1)。
  • 接触者IGRA阳性年发病率17.0/1000人年(95%CI 12.9-22.4)。
  • 接触者TST≥5mm阳性年发病率8.4/1000人年(95%CI 5.6-12.6)。
  • HIV感染者IGRA阳性年发病率16.9/1000人年(95%CI 10.5-27.3)。
  • HIV感染者TST≥5mm阳性年发病率27.1/1000人年(95%CI 15.0-49.0)。

临床怎么用

  • 可利用本综述的发病率数据评估高危人群潜伏结核感染检测与治疗的风险获益。
  • 对TST或IGRA阳性的高危人群,应考虑潜伏结核感染治疗决策。

局限性

  • 仅纳入英文或法文发表的研究。
  • 采用改良QUADAS-2工具评估质量,可能存在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the annual rate of tuberculosis development after a positive tuberculin skin test (TST) or interferon-gamma release assay result (IGRA), or both, among untreated populations with characteristics believed to increase the risk of tuberculosis (at risk populations). DESIGN: Systematic review and meta-analysis. DATA SOURCES: Embase, Medline, and Cochrane Controlled Register of Trials from 1 January 1990 to 17 May 2019, for studies in humans published in English or French. Reference lists were reviewed. ELIGIBILITY CRITERIA AND DATA ANALYSIS: Retrospective or prospective cohorts and randomised trials that included at least 10 untreated participants who tested positive to tuberculosis antigens (contained in TST or IGRA, or both) followed for at least 12 months. Following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) and meta-analyses of observational studies in epidemiology (MOOSE) guidelines, two reviewers independently extracted study data and assessed quality using a modified quality assessment of diagnostic accuracy studies (QUADAS-2) tool. Data were pooled using random effects generalised linear mixed models. MAIN OUTCOME MEASURES: The primary outcome was tuberculosis incidence per 1000 person years among untreated participants who tested positive (TST or IGRA, or both) in different at risk subgroups. Secondary outcomes were the cumulative incidence of tuberculosis and incidence rate ratios among participants with a positive test result for latent tuberculosis infection compared with those with a negative test result in at risk subgroups. RESULTS: 122 of 5166 identified studies were included. In three general population studies, the incidence of tuberculosis among 33 811 participants with a TST induration of ≥10 mm was 0.3 (95% confidence interval 0.1 to 1.1) per 1000 person years. Among 116 197 positive test results for latent tuberculosis infection in 19 different at risk populations, incidence rates were consistently higher than those in the general population. Among all types of tuberculosis contacts, the incidence of tuberculosis was 17.0 (95% confidence interval 12.9 to 22.4) per 1000 person years for participants with a positive IGRA result and 8.4 (5.6 to 12.6) per 1000 person years for participants with a positive TST result of ≥5 mm. Among people living with HIV, the incidence of tuberculosis was 16.9 (10.5 to 27.3) for participants with a positive IGRA result and 27.1 (15.0 to 49.0) for participants with a positive TST result of ≥5 mm. Rates were also high for immigrants, people with silicosis or requiring dialysis, transplant recipients, and prisoners. Incidence rate ratios among test positive versus test negative participants were significantly greater than 1.0 in almost all risk groups, for all tests. CONCLUSIONS: The incidence of tuberculosis is substantial in numerous at risk populations after a positive TST or IGRA result. The information from this review should help inform clinical decisions to test and treat for latent tuberculosis infection. STUDY REGISTRATION: PROSPERO CRD42019136608.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Campbell JR, Winters N, Menzies D, et al. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ. 2020. PMID: 32156698. doi:10.1136/bmj.m549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。